RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1, 2026. In this role, […]

Expands access to streamlined genomic data analysis across the PacBio partner ecosystem MENLO PARK, Calif. & BERLIN — PacBio (NASDAQ: PACB), a premier developer of sequencing solutions, and Lucid Genomics GmbH, a provider of cutting-edge bioinformatics software for clinical and research genomics, today announced that Lucid Genomics has joined the PacBio Compatible partner program as […]

ATLANTA, GA — Axion BioSystems, Inc., a leading provider of live-cell analysis technologies, today announced that Agilent Technologies, Inc. and Axion BioSystems have fully resolved the issues in the two lawsuits between them, pending in the United States District Court for the District of Delaware, pursuant to the terms of a confidential settlement agreement. Neither […]

Claret Bioscience and New England Biolabs (NEB® ) have entered into a co-promotion agreement to support researchers using SRSLY® MethylPlus in combination with the NEBNext® EM-seq™ v2 Conversion Module. SRSLY MethylPlus and SRSLY Uracil+ products are designed to integrate with enzymatic methyl-conversion workflows, enabling high-quality library preparation for methylation profiling and fragmentomics research. The collaboration […]

VANCOUVER, British Columbia — ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscribed $4.9M seed funding round led by Wittington Ventures. Additionally, new investors Continuum Health Ventures and Mayo Clinic contributed alongside repeat investors RiSC Capital, Debiopharm, […]

Orion HT and Orion LE extend the Orion platform from assay development through clinical trials, backed by an expanding biomarker reagent portfolio and commercial leadership focused on global growth SEATTLE — RareCyte®, a leader in precision biology products and technologies, today announced a significant expansion of its spatial proteomics portfolio with the commercial launch of […]

Expanded footprint delivers speed, scale and customization minimal residual disease (MRD) innovators need without compromising quality Increased production capacity leverages IDT’s highly specialized, high-throughput manufacturing platform  CORALVILLE, Iowa —Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, today announced the expansion of its manufacturing footprint in Coralville, Iowa. The investment delivers a […]

The Launch Early Access Program (LEAP) from Leica Microsystems provides supported access to the ATTOAuriga reagent platform Wetzlar, Germany –­ Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific solutions, announced today that its Launch Early Access Program (LEAP) is now available, offering supported early access to ATTOAuriga, a novel spatial […]

Enables Whole-Transcriptome In Situ Spatial Biology with Single-Cell Sensitivity at Scale Debuts at AACR Annual Meeting 2026 with Data from Leading Research Institutions, Including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research Institute (DKFZ) PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, […]

Saint Germain-en-Laye, France, San José, USA, and Helsinki, Finland – Life Science Newswire – Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high throughput antimicrobial resistance (AMR) surveillance from environmental samples. This collaboration unites Takara Bio’s scalable instrumentation with Resistomap’s environmental AMR intelligence to address […]